Your Cart ( 1 Item )

• Subgroup Analyses by European Country-Specific Reimbursement Requirements Confirm Efficacy for Ixekizumab in Psoriasis
  June 2022 | Volume 21 | Issue 6 | Original Article | 659 | Copyright © June 2022
  Elisabeth Riedl MD^a, Ulrich Mrowietz MD^b, Julie Hill B. Pharm MBA^c, Christophe Sapin PhD^d, Richard B. Warren MD^e
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs